Logo image of DEX.MI

DEXELANCE SPA (DEX.MI) Stock Fundamental Analysis

BIT:DEX - Euronext Milan - IT0005543480 - Common Stock - Currency: EUR

7.94  -0.04 (-0.5%)

Fundamental Rating

5

DEX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 33 industry peers in the Household Durables industry. Both the profitability and the financial health of DEX get a neutral evaluation. Nothing too spectacular is happening here. DEX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

DEX had positive earnings in the past year.
In the past year DEX had a positive cash flow from operations.
Of the past 5 years DEX 4 years were profitable.
In the past 5 years DEX always reported a positive cash flow from operatings.
DEX.MI Yearly Net Income VS EBIT VS OCF VS FCFDEX.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 10M 20M 30M

1.2 Ratios

DEX has a Return On Assets of 4.04%. This is in the better half of the industry: DEX outperforms 72.73% of its industry peers.
DEX has a Return On Equity of 10.92%. This is in the better half of the industry: DEX outperforms 66.67% of its industry peers.
With a decent Return On Invested Capital value of 7.68%, DEX is doing good in the industry, outperforming 69.70% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for DEX is significantly below the industry average of 14.77%.
Industry RankSector Rank
ROA 4.04%
ROE 10.92%
ROIC 7.68%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
DEX.MI Yearly ROA, ROE, ROICDEX.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

The Profit Margin of DEX (3.83%) is better than 60.61% of its industry peers.
DEX's Profit Margin has declined in the last couple of years.
DEX has a better Operating Margin (7.13%) than 60.61% of its industry peers.
In the last couple of years the Operating Margin of DEX has declined.
With a Gross Margin value of 39.27%, DEX perfoms like the industry average, outperforming 48.48% of the companies in the same industry.
In the last couple of years the Gross Margin of DEX has grown nicely.
Industry RankSector Rank
OM 7.13%
PM (TTM) 3.83%
GM 39.27%
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
DEX.MI Yearly Profit, Operating, Gross MarginsDEX.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DEX is still creating some value.
Compared to 1 year ago, DEX has about the same amount of shares outstanding.
Compared to 1 year ago, DEX has an improved debt to assets ratio.
DEX.MI Yearly Shares OutstandingDEX.MI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
DEX.MI Yearly Total Debt VS Total AssetsDEX.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

DEX has an Altman-Z score of 2.03. This is not the best score and indicates that DEX is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.03, DEX perfoms like the industry average, outperforming 48.48% of the companies in the same industry.
DEX has a debt to FCF ratio of 4.55. This is a neutral value as DEX would need 4.55 years to pay back of all of its debts.
The Debt to FCF ratio of DEX (4.55) is better than 69.70% of its industry peers.
A Debt/Equity ratio of 0.38 indicates that DEX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.38, DEX is in line with its industry, outperforming 57.58% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.55
Altman-Z 2.03
ROIC/WACC1.12
WACC6.88%
DEX.MI Yearly LT Debt VS Equity VS FCFDEX.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.12 indicates that DEX should not have too much problems paying its short term obligations.
The Current ratio of DEX (1.12) is worse than 72.73% of its industry peers.
A Quick Ratio of 0.81 indicates that DEX may have some problems paying its short term obligations.
DEX has a Quick ratio of 0.81. This is comparable to the rest of the industry: DEX outperforms 42.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.81
DEX.MI Yearly Current Assets VS Current LiabilitesDEX.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

5

3. Growth

3.1 Past

DEX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -44.20%.
The Earnings Per Share has been growing by 16.38% on average over the past years. This is quite good.
DEX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.85%.
DEX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.04% yearly.
EPS 1Y (TTM)-44.2%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-954.7%
Revenue 1Y (TTM)12.85%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%-0.87%

3.2 Future

DEX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.44% yearly.
The Revenue is expected to grow by 4.56% on average over the next years.
EPS Next Y17.06%
EPS Next 2Y12.08%
EPS Next 3Y8.44%
EPS Next 5YN/A
Revenue Next Year4.98%
Revenue Next 2Y5.09%
Revenue Next 3Y4.56%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DEX.MI Yearly Revenue VS EstimatesDEX.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
DEX.MI Yearly EPS VS EstimatesDEX.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 12.03, DEX is valued correctly.
The rest of the industry has a similar Price/Earnings ratio as DEX.
DEX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.43.
The Price/Forward Earnings ratio is 7.39, which indicates a rather cheap valuation of DEX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of DEX indicates a somewhat cheap valuation: DEX is cheaper than 72.73% of the companies listed in the same industry.
DEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.17, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.03
Fwd PE 7.39
DEX.MI Price Earnings VS Forward Price EarningsDEX.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

81.82% of the companies in the same industry are more expensive than DEX, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of DEX indicates a somewhat cheap valuation: DEX is cheaper than 69.70% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.48
EV/EBITDA 4.31
DEX.MI Per share dataDEX.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

DEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.71
PEG (5Y)N/A
EPS Next 2Y12.08%
EPS Next 3Y8.44%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for DEX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

DEXELANCE SPA

BIT:DEX (6/2/2025, 3:58:47 PM)

7.94

-0.04 (-0.5%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners14.73%
Inst Owner ChangeN/A
Ins Owners3.17%
Ins Owner ChangeN/A
Market Cap213.82M
Analysts88.57
Price Target13.4 (68.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-6.86%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.49%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 12.03
Fwd PE 7.39
P/S 0.45
P/FCF 10.48
P/OCF 8.45
P/B 1.28
P/tB N/A
EV/EBITDA 4.31
EPS(TTM)0.66
EY8.31%
EPS(NY)1.07
Fwd EY13.53%
FCF(TTM)0.76
FCFY9.54%
OCF(TTM)0.94
OCFY11.83%
SpS17.72
BVpS6.21
TBVpS-2.46
PEG (NY)0.71
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.04%
ROE 10.92%
ROCE 10.57%
ROIC 7.68%
ROICexc 8.82%
ROICexgc 52.73%
OM 7.13%
PM (TTM) 3.83%
GM 39.27%
FCFM 4.27%
ROA(3y)2.51%
ROA(5y)3.41%
ROE(3y)6.18%
ROE(5y)10.61%
ROIC(3y)7.89%
ROIC(5y)6.91%
ROICexc(3y)10.38%
ROICexc(5y)9.17%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)10.86%
ROCE(5y)9.5%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-10.93%
ROICexc growth 5YN/A
OM growth 3Y-4.54%
OM growth 5YN/A
PM growth 3Y-11.3%
PM growth 5YN/A
GM growth 3Y7.21%
GM growth 5YN/A
F-Score7
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 4.55
Debt/EBITDA 1.11
Cap/Depr 21.25%
Cap/Sales 1.03%
Interest Coverage 250
Cash Conversion 44.3%
Profit Quality 111.6%
Current Ratio 1.12
Quick Ratio 0.81
Altman-Z 2.03
F-Score7
WACC6.88%
ROIC/WACC1.12
Cap/Depr(3y)32.47%
Cap/Depr(5y)34.25%
Cap/Sales(3y)1.91%
Cap/Sales(5y)2.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.2%
EPS 3Y16.38%
EPS 5YN/A
EPS Q2Q%-954.7%
EPS Next Y17.06%
EPS Next 2Y12.08%
EPS Next 3Y8.44%
EPS Next 5YN/A
Revenue 1Y (TTM)12.85%
Revenue growth 3Y31.04%
Revenue growth 5YN/A
Sales Q2Q%-0.87%
Revenue Next Year4.98%
Revenue Next 2Y5.09%
Revenue Next 3Y4.56%
Revenue Next 5YN/A
EBIT growth 1Y-22.63%
EBIT growth 3Y25.09%
EBIT growth 5YN/A
EBIT Next Year47.8%
EBIT Next 3Y13.65%
EBIT Next 5YN/A
FCF growth 1Y157.29%
FCF growth 3Y8.28%
FCF growth 5YN/A
OCF growth 1Y97.69%
OCF growth 3Y11.3%
OCF growth 5YN/A